High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate.
Cocrystal has attracted much attention in order to improve poor physicochemical properties, since cocrystal former crystallize with the ionic drugs as well as nonionic drugs. Cocrystal screening was usually conducted by crystallization, slurry and co-grinding techniques, however sensitivity, cost and time for screening were limited because of issues such as dissociation of cocrystal during crystallization and cost and time required for slurry and co-grinding methods. To overcome these issues, novel high-throughput cocrystal slurry screening was developed by using in situ Raman microscope and a multi-well plate. Cocrystal screening of indomethacin was conducted with 46 cocrystal formers and potential cocrystals were prepared on a large scale for the characterization with powder X-ray diffractometry, thermal analysis, and Raman microscopy and (1)H NMR spectroscopy. Compared with the characterization of scale-up cocrystals, the cocrystal screening indicated that indomethacin structured novel cocrystals with D/L-mandelic acid, nicotinamide, lactamide and benzamide which was not obtained in the screening with crystallization technique previously reported. In addition, the screening provided not only information of cocrystal formation within a day but also information of equilibrium of cocrystal formation and polymorphic transformation in one screening. Information obtained in this screening allows effective solid form selection by saving cost and time for the development.
Kojima
Takashi
T
Pharmaceutical Research Division, Takeda Pharmaceutical Company Ltd., Yodogawa-ku, Osaka, Japan. Kojima_Takashi@takeda.co.jp
Tsutsumi
Shunichirou
S
Yamamoto
Katsuhiko
K
Ikeda
Yukihiro
Y
Moriwaki
Toshiya
T
D003460:Crystallization; D004339:Drug Compounding / Q000379:methods*; D005079:Excipients / Q000737:chemistry; D007213:Indomethacin / Q000737:chemistry; D009682:Magnetic Resonance Spectroscopy; D008859:Microscopy, Polarization; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D033362:Powder Diffraction; D013059:Spectrum Analysis, Raman; D014961:X-Ray Diffraction
D005079:Excipients; D004364:Pharmaceutical Preparations; D007213:Indomethacin